Network
Biotech Business is supporting a range of companies to plan and implement their strategic business development activities. Some examples of our current clients and projects include:
- • A UK anti-infectives and oncology biotech company with two late-preclinical vaccines focused on viral disease, earlier vaccines for viral and bacterial disease and a selective synthetic drug-toxin conjugate that targets and kills oestrogen receptor positive breast cancer
- • A US oncology company with a clinical stage oncology cotherapy platform that is also exploring in- and out-licensing opportunities for use of their technology with oncology MAbs
- • A major Japanese company with a novel protein expression system for use with therapeutic proteins that are difficult to express in E coli and other standard expression systems
- • A UK biotech developing small molecule antibiotics and looking for anti-fungals
and other opportunities in infectious disease - • A German university spin-out offering screening and libraries of extracts derived from marine biodiversity
- • A UK university spin-out discovery and reprofiling company
We would be pleased to provide more information on our existing network of clients as well as a selection of consultants that can assist with CMC, supply chain management, data security and other drug discovery and development issues.